Subchronic 90-day feeding studies were conducted in male and female Fischer-344 (F-344) rats on highly refined white mineral oils and waxes representative of those used for food applications. The goal was to help clarify the mixed results found in other toxicity studies with laboratory animals. Seven white oils and 5 waxes were fed at dietary doses of 20,000, 2,000, 200, and 20 ppm and compared with control groups on untreated diet; toxicity was assessed at 90 days and also after a reversal period of 28 days and/or 85 days. Higher molecular-sized hydrocarbons (microcrystalline waxes and the higher viscosity oils) were without biological effects. Paraffin waxes and low- to midviscosity oils produced biological effects that were inversely related to molecular weight, viscosity, and melting point; oil type and processing did not appear to be determinants. Biological effects were more pronounced in females than in males. Effects occurred mainly in the liver and mesenteric lymph nodes and included increased organ weights, microscopic inflammatory changes, and evidence for the presence of saturated mineral hydrocarbons in affected tissues. Inflammation of the cardiac mitral valve was also observed at high doses in rats treated with paraffin waxes. Further studies are required to elucidate the mechanism for the responses observed and the relevance of these inflammatory responses in the F-344 rat to other species, including humans.
Albro PW and Fishbein L. (1970). Absorption of aliphatic hydrocarbons by rats. Biochim. Biophys. Acta219(2): 437-446.
2.
Baldwin MK, Berry PH, Esdaile DJ, Linnett SL, Martin JG, Peristianis GC, Priston RAJ, Simpson BJE, and Smith JD (1992). Feeding studies in rats with mineral hydrocarbon food grade white oils. Toxicol. Pathol. 20(3): 426-435.
3.
Barrowman JA , Rahman A., Lindstrom MB, and Borgstrom B. (1989). Intestinal absorption and metabolism of hydrocarbons. Prog. Lipid Res. 28: 189-203.
4.
Boitnott JK and Margolis S. (1966). Mineral oil in human tissues. II. Oil droplets in lymph nodes of the porta hepatis. Bull. Johns Hopkins Hosp . 118: 414-422.
5.
Boitnott JK and Margolis S. (1970). Saturated hydrocarbons in human tissues. III. Oil droplets in the liver and spleen. Johns Hopkins Med. J . 127: 65-78.
6.
Dincsoy HP, Weesner RE, and MacGee J. (1982). Lipogranulomas in non-fatty human livers. A mineral oil induced environmental disease. Am. J. Clin. Pathol. 78(1): 35-41.
7.
Durand E. and Tulliez J. (1980). Microsomal oxidation of linear, branched and cyclic paraffins in rat liver. Ann. Nutr. Alim. 34: 491-492.
8.
Ebert AG, Schleifer CR, and Hess SM (1966). Absorption, disposition, and excretion of 3H-mineral oil in rats. J. Pharmaceut. Sci. 55(9): 923-929.
9.
Firriolo JM, Morris CF, Trimmer GW, Twitty LD, Smith JH, and Freeman JJ (1995). Comparative 90-day feeding study with low viscosity white mineral oil in Fischer-344 and Sprague-Dawley-derived CRL:CD rats. Toxicol. Pathol. 23(1): 26-33.
10.
Freeman JJ, Simpson BJ, and Tietze P. (1993). White Oil and Waxes-Summary of 90-Day Studies . Report No. 93/56, CONCAWE, Brussels , 13 pp.
11.
Gerarde HW and Gerarde DF (1961/1962). The ubiquitous hydrocarbons . Assoc. Food Drug Officials U.S. XXV and XXVI: 1-47.
12.
Hulse M., Klan MJ, Noreyko JM, Reitman FA, Skisak CM, Smith JH, Tietze PG, and Vernot EH (1992). American Petroleum Institute (API) Mineral Oil Review. API, Washington, D.C.
13.
Institute of Shortening and Edible Oils (1988). Food Fats and Oils, Washington, D.C., pp. 1-27.
14.
Kelsall GRH and Blackwell JB (1969). The occurrence and significance of lipophage clusters in lymph nodes and spleen. Pathology1: 211-220.
15.
Kolattukudy PE and Hankin L. (1966). Metabolism of a plant wax paraffin (n-nonacosane) in the rat. J. Nutr . 90: 167-174.
16.
Le Bon AM, Cravedi JP, and Tulliez JE (1988). Disposition and metabolism of pristane in rat. Lipids23(5): 424-429.
17.
Lester DE (1979). Normal paraffins in living matter-Occurrence, metabolism, and pathology. Prog. Food Nutr. Sci. 3: 1-66.
18.
Low LK, Shymanski PM, Kommineni C., Naro PA, and Mackerer CR (1992). Oral absorption and pharmacokinetic studies of radiolabelled normal paraffinic, isoparaffinic and cycloparaffinic surrogates in white oil in Fischer 344 rats. In: Special Meeting on Mineral Hydrocarbons. The Toxicology Forum, Oxford, UK, pp. 86- 101.
19.
Matschiner JT , Hsia SL, and Doisy EA (1967). Effect of indigestible oils on vitamin K deficiency in the rat. J. Nutr . 91: 299-302.
McKee RH , Plutnick RT, and Traul KA (1987). Assessment of the potential reproductive and subchronic toxicity of EDS coal liquids in Sprague Dawley rats. Toxicology46: 267-280.
22.
McTurk LC and Eckardt RE (1960). Consideration of the Safety to Public Health on the Inclusion of White Mineral Oil in Food . Reprinted for the American College of Allergists Las Vegas Meeting , April 9, 1965. Humble Oil and Refining Company , Houston, Texas.
23.
Michalczyk G. (1992). Specification-Waxes . In: Special Meeting on Mineral Hydrocarbons. The Toxicology Forum, Oxford, UK, pp. 24-30.
24.
Mitchell MP and Hübscher G. (1968). Oxidation of n-hexadecane by subcellular preparations of guinea pig small intestine. Eur. J. Biochem. 7: 90-95.
25.
Morita T., Ebihara K., and Kiriyama S. (1993). Dietary fiber and fat-derivatives prevent mineral oil toxicity in rats by the same mechanism. J. Nutr. 123: 1575-1585.
26.
Morris CF, Lindemann KC, Miller MJ, Nicolich MJ, and Smith JH (1995). The Oral Toxicity of White Oil and Wax Mineral Hydrocarbons: Consideration of Liver and Mesenteric Lymph Node Histopathology Effects. Unpublished report.
27.
National Toxicology Program ( 1986). Toxicology and Carcinogenesis Studies of Chlorinated Paraffins (C23, 43% Chlorine, CAS No. 63449-39-8) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP Toxicity Report No. 305, NIH Publication No. 86-2561, 202 pp.
28.
Oser BL, Oser M., Carson S., and Sternberg SS (1965). Toxicologic studies of petrolatum in mice and rats. Toxicol. Appl. Pharmacol. 7: 382-401.
29.
Perdu-Durand EF and Tulliez JE (1985). Hydrocarbon hydroxylation system in liver microsomes from four animal species. Fd. Chem. Toxicol. 23(3): 363-366.
30.
Roger Y. (1992). Specification-Oils. In: Special Meeting on Mineral Hydrocarbons. The Toxicology Forum, Oxford, UK, pp. 15-23.
31.
Salvayre R. , Nègre A., Rocchiccioli F., Duboucher C., Maret A., Vieu C., Lageron A., Polonovski J., and Douste-Blazy L. (1988). A new human pathology with visceral accumulation of long-chain n-alkanes ; tissue distribution of the stored compounds and pathophysiological hypotheses . Biochim. Biophys. Acta958: 477-483.
32.
Schmähl D. and Reiter A. (1953). Experiments to create cancer with liquid paraffin, yellow petrolatum, and wool fat. Arz. Forsch. 3: 403-406.
33.
Shubik P., Saffiotti U., Lijinsky W., Pietta G., Rappaport H., Toth B., Raha CR, Tomatis LK, Feldman R., and Ramati H. (1962). Studies on the toxicity of petroleum waxes. Toxicol. Appl. Pharmacol.4(suppl.): 1-62.
34.
Smith JH, Bird MG, Lewis SC, Freeman JJ, Hogan GK, and Scala RA (1995). Subchronic feeding study of four white mineral oils in dogs and rats. Drug Chem. Toxicol. 18(1): 83-103.
35.
Steigmann F. , Popper H., Dyniewicz H., and Maxwell I. (1952). Critical levels of mineral oil affecting the absorption of vitamin A. Gastroenterology20(4): 587-594.
36.
Stryker WA (1941). Absorption of liquid petrolatum ("mineral oil") from the intestine. Arch. Pathol. 31: 670-692.
37.
Tietze P. (1992). Manufacturing processes. In: Special Meeting on Mineral Hydrocarbons. The Toxicology Forum, Oxford, UK, pp. 3-14.
38.
Tulliez JE and Bories GF (1975). Metabolism of paraffinic and naphthenic hydrocarbons in the higher animals. I. Retention of normal, cyclic, and branched paraffins in the rat. Ann. Nutr. Alim. 29: 201-211.
39.
Tulliez JE and Bories GF (1975). Metabolism of paraffinic and naphthenic hydrocarbons in the higher animals. II. Accumulation and mobilization in the rat. Ann. Nutr. Alim. 29: 213-221.
40.
Tulliez JE and Bories GF (1978). Metabolism of a n-paraffin, heptadecane, in rats . Lipids13(2): 110-115.
41.
Tulliez J. and Durand E. (1980). Mitochondrial hydroxylation as a result of β-oxidation blockade of a cyclohexyl substituted fatty acid. Ann. Nutr. Alim. 34: 492-494.
42.
Urbach G. and Stark W. (1975). The C-20 hydrocarbons of butterfat. J. Agr. Food Chem. 23(1): 20-24.
43.
U.S. Food and Drug Administration (1978). Regulations for Non-Clinical Laboratory Studies . 43FR 59986 (December 22, 1978) and subsequent revisions, FDA, Washington, D.C.
44.
Walters DG, Sherrington KV, Worrell N., and Riley RA (1994). Formulation and analysis of food-grade mineral hydrocarbons in toxicology studies. Food Chem. Toxicol. 32(6): 549-557.
45.
Wanless IR and Geddie WR (1985). Mineral oil lipogranulomata in liver and spleen . Arch. Pathol. Lab. Med. 109: 283-286.
46.
Ward JM, Uno H., and Frith CH (1993). Immunohistochemistry and morphology of reactive lesions in lymph nodes and spleen in rats and mice. Toxicol. Pathol. 21(2): 199-205.
47.
Zimmerman HJ , Sternberg S., Althoff J., and Fleming K. (1992). Expert panel: Significance of studies/review of pathology. In: Special Meeting on Mineral Hydrocarbons. The Toxicology Forum, Oxford, UK, pp. 102-108.
48.
Zimmerman HJ , Moch RW, Althoff J., and Fleming K. (1993). Mineral hydrocarbons: Pathology discussion. In: The Toxicology Forum: 1993 Annual Winter Meeting. The Toxicology Forum, Washington, D.C., pp. 178-187.
